Home / Market News / $GEHC
fiscal.ai Corporate Catalyst Impact 65/100 ● neutral

Analysts Adjust Price Targets for GE HealthCare Technologies

Oct 29, 2026, 1:33 PM UTC · Primary ticker $GEHC

Multiple financial analysts, including RBC, Rothschild & Co Redburn, and BNP Paribas, have increased their price targets for GE HealthCare Technologies following its recent quarterly earnings report. This indicates a positive sentiment from these firms regarding the company's future performance and valuation.

This 8-K filing discloses that several prominent financial analysts have raised their price targets for GE HealthCare Technologies (GEHC) after the company's latest quarterly earnings report. RBC increased its target from $80 to $90, maintaining an Outperform rating, while Rothschild & Co Redburn and BNP Paribas both adjusted their targets from $96 to $100. This collective upward revision in price targets suggests that these analysts view the company's recent performance favorably and anticipate continued growth or improved valuation. For traders, this indicates a positive short-term sentiment and could lead to increased buying interest in GEHC shares, potentially driving the stock price higher. The long-term implication is a reinforced positive outlook for the company's fundamentals, though market reactions can be influenced by broader sector trends and overall market conditions.

$GEHC positive Analyst price target increases
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.